department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

GC Biopharma Corp · pharmadog

PUBLIC COMPANY

GC Biopharma Corp

updated 1mo ago

community read0 votes

pipeline

3

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

1Phase 11Phase 21Phase 3

Primary Humoral Immune Deficiencies

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view GC Biopharma Corp jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase3A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Yearsrecruitingn=474
phase3An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)completedn=30
phase1A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patientcompletedn=15
phase2A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Diseaserecruitingn=18
phase1Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)recruitingn=9
phase3Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiencyactive not recruitingn=24
—Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Studyactive not recruitingn=1,563
phase2A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adultsrecruitingn=120

more trials →